penumbrainc.com - PEN Total Company Value-to-Revenue Ratio

Penumbra Inc (PEN) - corporate logo

Penumbra, Inc. (PEN) leadership in aspiration thrombectomy eliminates pricing pressure, which is confirmed by the enterprise value-to-revenue multiple. Demand for Lightning Flash systems and global expansion are driving growth, while the introduction of new catheters is shaping future revenues. The value 7786.03 represents the current metric, indicating a high market valuation of the business relative to its operating sales.

Penumbra Corp (PEN) EV/Sales Multiple: for the period 11/23/2025 - 11/20/2026

Financial and market metric breakdowns for Penumbra Corp (PEN)

- share price and consensus valuation forecast:
Fundamental company valuation:PEN, penumbrainc.com
Flagship merchandise of Penumbra Inc

Penumbra, Inc. (PEN) leads in neurovascular surgery thanks to its unique clot aspiration technologies for strokes. This indicator compares the total enterprise value to annual revenue, excluding the impact of debt load to reveal the actual market valuation of assets. By analyzing the enterprise value-to-revenue multiple, an investor determines the extent of the premium paid for innovation or the risk of a "value trap" in the event of stagnating fundamental metrics.

Competitor analysis

Enterprise Value-to-Revenue Multiple DexCom, Inc.|NOVT: EV/Sales Multiple|HAE - Total Company Value-to-Revenue Ratio|INSP (Inspire Medical Systems Inc) - EV/Sales Multiple|PROCEPT BioRobotics Inc (PRCT) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple CNMD|Company Value to Revenue Pulse Biosciences, Inc. PLSE|EV/Sales Multiple INMD (inmodemd.com)|Picard Medical Inc. - Enterprise Value-to-Revenue Ratio|SRDX - Enterprise Value-to-Revenue Ratio|SENS: Enterprise Value-to-Revenue Ratio|NPCE (NeuroPace, Inc.) - Company Value to Revenue|Tactile Systems Technology, Inc. - Business Value to Revenue|SNWV (SANUWAVE Health Inc) - EV/Sales Multiple|EV/Sales Multiple Outset Medical|Enterprise Value-to-Revenue Ratio Electromed (ELMD)|LENSAR, Inc. (LNSR) - Enterprise Value-to-Sales Ratio|AVITA Medical Inc - Company Value to Revenue|EV/Sales Multiple Profound Medical Corporation PROF|Baird Medical Investment Holdings - EV/Sales Multiple|Total Company Value-to-Revenue Ratio EDAP TMS EDAP|Apyx Medical Corporation (APYX) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume ICCM (IceCure Medical, Ltd.)|Enterprise Value-to-Revenue Ratio pulmonx.com|Company Value to Revenue TELA Bio, Inc. (TELA)|EV/Sales Multiple CTSO|SRTS - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Zynex, Inc. ZYXI|ECOR: Company Value to Revenue Ratio|RBOT: Company Value to Revenue|inspira-technologies.com - Enterprise Value-to-Revenue Coefficient|ICU: EV/Sales Multiple|IRIX - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Intelligent Bio Solutions Inc.|Enterprise Value-to-Revenue Multiple Beyond Air XAIR|Enterprise Value-to-Revenue Ratio Profusa Inc. (PFSA)|SSKN (STRATA Skin Sciences, Inc.) - Business Value to Revenue|EV/Sales Multiple GCTK (GlucoTrack Inc.)|NanoVibronix, Inc. (NAOV) - Enterprise Value-to-Revenue Multiple|VERO - Enterprise Value-to-Revenue Ratio|NUWE: Enterprise Value-to-Revenue Ratio|Aethlon Medical Inc (AEMD) - Enterprise Value-to-Revenue Ratio|TransEnterix (ASXC) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio Avinger|BSGM: Business Value to Revenue|EV/Sales Multiple CUTR|Total Company Value-to-Revenue Ratio Know Labs, Inc.|EV/Sales Multiple NARI (Inari Medical)|Business Value to Revenue NVRO|ReShape Lifesciences, Inc. - EV/Sales Multiple|Business Value to Revenue SILK (Silk Road Medical, Inc.)